Prognostic significance of new onset atrial fibrillation in acute coronary syndrome patients treated conservatively

Cardiology Journal

Volumn 17, Issue 1, 2010, Pages 57-64

  Dziewierz, Artur ^a   Siudak, Zbigniew ^a   Rakowski, Tomasz ^a   Jákała, Jacek ^a   Dubiel, Jacek S ^a   Dudek, Dariusz ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Acute coronary syndrome; Atrial fibrillation; Management; Mortality; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN II ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; NITRATE; TICLOPIDINE;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; CARDIOGENIC SHOCK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONSERVATIVE TREATMENT; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; SYMPTOM; THORAX PAIN;

ACUTE CORONARY SYNDROME; AGE FACTORS; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; FEMALE; FIBRINOLYTIC AGENTS; HOSPITAL MORTALITY; HOSPITALIZATION; HOSPITALS, COMMUNITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KIDNEY FAILURE; MALE; PATIENT ADMISSION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SHOCK, CARDIOGENIC; TIME FACTORS;

EID: 75749106602     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Lopes RD, Pieper KS, Horton JR et al. Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation. Heart, 2008; 94: 867-873.
2. Pizzetti F, Turazza FM, Franzosi MG et al. Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: The GISSI-3 data. Heart, 2001; 86: 527-532.
3. Behar S, Zahavi Z, Goldbourt U, Reicher-Reiss H. Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction. SPRINT Study Group. Eur Heart J, 1992; 13: 45-50.
4. Pedersen OD, Bagger H, Kober L, Torp-Pedersen C. The occurrence and prognostic significance of atrial fibrillation/flutter following acute myocardial infarction. TRACE Study group. TRAndolapril Cardiac Evalution. Eur Heart J, 1999; 20: 748-754.
5. Rathore SS, Berger AK, Weinfurt KP et al. Acute myocardial infarction complicated by atrial fibrillation in the elderly: Prevalence and outcomes. Circulation, 2000; 101: 969-974.
6. Eldar M, Canetti M, Rotstein Z et al. Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era. SPRINT and Thrombolytic Survey Groups. Circulation, 1998; 97: 965-970.
7. Wong CK, White HD, Wilcox RG et al. New atrial fibrillation after acute myocardial infarction independently predicts death: The GUSTO-III experience. Am Heart J, 2000; 140: 878-885.
8. Mehta RH, Dabbous OH, Granger CB et al. Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation. Am J Cardiol, 2003; 92: 1031-1036.
9. Al-Khatib SM, Pieper KS, Lee KL et al. Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: Results from the PURSUIT trial. Am J Cardiol, 2001; 88 (A7): 76-79.
10. Berton G, Cordiano R, Cucchini F, Cavuto F, Pellegrinet M, Palatini P. Atrial fibrillation during acute myocardial infarction: Association with all-cause mortality and sudden death after 7-year of follow-up. Int J Clin Pract, 2009; 63: 712-721.
11. Cappato R. Atrial fibrillation complicating acute myocardial infarction: How should it be interpreted and how should it be treated and prevented? Eur Heart J, 2009; 30: 1035-1037.
12. Schmitt J, Duray G, Gersh BJ, Hohnloser SH. Atrial fibrillation in acute myocardial infarction: A systematic review of the incidence, clinical features and prognostic implications. Eur Heart J, 2009; 30: 1038-1045.
13. Siu CW, Jim MH, Ho HH et al. Transient atrial fibrillation complicating acute inferior myocardial infarction: Implications for future risk of ischemic stroke. Chest, 2007; 132: 44-49.
14. Goldberg RJ, Yarzebski J, Lessard D, Wu J, Gore JM. Recent trends in the incidence rates of, and death rates from, atrial fibrillation complicating initial acute myocardial infarction: A community-wide perspective. Am Heart J, 2002; 143: 519-527.
15. Ramani G, Zahid M, Good CB, Macioce A, Sonel AF. Comparison of frequency of new-onset atrial fibrillation or flutter in patients on statins versus not on statins presenting with suspected acute coronary syndrome. Am J Cardiol, 2007; 100: 404-405.
16. Adam O, Neuberger HR, Bohm M, Laufs U. Prevention of atrial fibrillation with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Circulation, 2008; 118: 1285-1293.
17. Dudek D, Siudak Z, Dziewierz A et al. Local hospital networks for STEMI treatment for a population of half a million inhabitants increase the use of invasive treatment of acute coronary syndromes to the European recommended level. The Malopolska Registry of Acute Coronary Syndromes 2005-2006. Kardiol Pol, 2008; 66: 489-497.
18. Dziewierz A, Siudak Z, Rakowski T et al. More aggressive pharmacological treatment may improve clinical outcome in patients with non-ST-elevation acute coronary syndromes treated conservatively. Coron Artery Dis, 2007; 18: 299-303.
19. Nieminen MS, Bohm M, Cowie MR et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J, 2005; 26: 384-416.
20. Helmers C, Lundman T, Mogensen L, Orinius E, Sjogren A, Wester PO. Atrial fibrillation in acute myocardial infarction. Acta Med Scand, 1973; 193: 39-44.
21. Melloni C, Mahaffey KW. Management of acute coronary syndromes in patients with renal dysfunction. Curr Opin Cardiol, 2008; 23: 320-326.
22. Dudek D, Chyrchel B, Siudak Z et al. Renal insufficiency increases mortality in acute coronary syndromes regardless of TIMI risk score. Kardiol Pol, 2008; 66: 28-34.
23. Salisbury AC, Reid KJ, Spertus JA. Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes. Am J Cardiol, 2007; 99: 636-641.
24. Mukherjee D, Eagle KA, Kline-Rogers E et al. Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the Global Registry of Acute Coronary Events). Am J Cardiol, 2007; 100: 1-6.
25. Donahoe SM, Stewart GC, McCabe CH et al. Diabetes and mortality following acute coronary syndromes. JAMA, 2007; 298: 765-775.
26. Lau CP, Leung WH, Wong CK, Cheng CH. Haemodynamics of induced atrial fibrillation: A comparative assessment with sinus rhythm, atrial and ventricular pacing. Eur Heart J, 1990; 11: 219-224.
27. Sowton E. Hemodynamic consequences of arrhythmias. J Cardiovasc Pharmacol, 1991; 17 (suppl. 6): S20-S23.
28. Steg PG, Goldberg RJ, Gore JM et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol, 2002; 90: 358-363.
29. Dziewierz A, Siudak Z, Rakowski T et al. In-hospital management and mortality in elderly patients with non-ST-segment elevation acute coronary syndromes treated in centers without on-site invasive facilities. Cardiol J, 2008; 15: 451-457.
30. Avezum A, Makdisse M, Spencer F et al. Impact of age on management and outcome of acute coronary syndrome: Observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J, 2005; 149: 67-73.